(Q37164808)

18 August 2017

1 reference

title

Advances in the field of cannabinoid--opioid cross-talk (English)

1 reference

18 August 2017

0 references

0 references

Andrés Ozaita

3

0 references

author name string

Patricia Robledo

series ordinal

1

1 reference

18 August 2017

Fernando Berrendero

series ordinal

2

1 reference

18 August 2017

Rafael Maldonado

series ordinal

4

1 reference

18 August 2017

language of work or name

1 reference

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

13

1 reference

18 August 2017

2

1 reference

18 August 2017

213-224

1 reference

Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

In silico patent searching reveals a new cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Synergistic interactions between cannabinoid and opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid/opioid crosstalk in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Anandamide and memory in CD1 mice: effects of immobilization stress and of prior experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Effects of anandamide and morphine combinations on memory consolidation in cd1 mice: involvement of dopaminergic mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid CB1 receptors control conditioned drug seeking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

The GTP-binding protein, Go, regulates neuronal calcium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

The cannabinoid receptor: biochemical, anatomical and behavioral characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Central glucocorticoid receptors modulate the expression of spinal cannabinoid receptors induced by chronic morphine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Study of cannabinoid dependence in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Involvement of the endocannabinoid system in drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Pharmacological and biochemical interactions between opioids and cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid agonist-induced sensitisation to morphine place preference in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Opiate activation of potassium conductance in myenteric neurons: inhibition by calcium ion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Opioids block long-term potentiation of inhibitory synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

The endocannabinoid system as an emerging target of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Behavioral sensitization to heroin by cannabinoid pretreatment in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Behavioral sensitization to WIN55212.2 in rats pretreated with heroin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

The neural basis of drug craving: an incentive-sensitization theory of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

The psychoactive ingredient of marijuana induces behavioural sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Modulation of transmitter release via presynaptic cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2008.00107.X

10.1111/J.1369-1600.2008.00107.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference